£7.3M
The financing round was led by Vulpes Investment Management with backing from existing investors to fund first in-human data acquisition.
Oxford Endovascular
Oxford Endovascular develops origami engineered medical devices to prevent brain haemorrhage.
£7.3MTotal raised
Oxford Endovascular is a medical technology company developing origami engineered micro stents to treat brain aneurysms. The firm emerged as a spin out from the University of Oxford.
Categories
Team
Mike Karim
CEO
Mike brings healthtech and commercial experience from roles including chief executive officer at Oxford Endovascular and chief commercial officer at Medistim ASA. He also serves as a venture partner at Synapto Ventures and a non-executive board member at OBN.
LinkedIn